Mutation Linked to Increased Risk of Prostate Cancer Mortality Cancer-specific mortality twice as high in patients with specific genotype for HSD3B1 allele Mar 20, 2024
England's NHS Clinics No Longer Offering Puberty Blockers to Trans Youth Final policy will allow prescriptions only via clinical trials, or for existing patients Mar 14, 2024
Beyond Kegels: Brittany Mahomes' Pelvic Floor Woes Post-Childbirth An ob/gyn and a pelvic floor physical therapist weigh in Mar 12, 2024
Trump-Obama Doc's Bad Behavior; Alzheimer's Drug Delayed; Death After Testicle Kick Health news and commentary from around the Web gathered by app staff Mar 08, 2024
First-Line Nivolumab Plus Chemo Approved for Bladder Cancer Combination reduced risk of death by 22% Mar 07, 2024
King Charles' Cancer Diagnosis Highlights Long Wait Times Across the Pond Survival for common cancers in the U.K. consistently lags behind Mar 06, 2024
Study Tests Office-Based Transperineal Approach to Prostate Biopsies Antibiotic-free option resulted in zero infections in randomized trial Feb 29, 2024 video
FDA Approves Antibiotic Combination for Complicated UTIs Cefepime-enmetazobactam beat piperacillin-tazobactam in phase III study Feb 23, 2024
Another COVID Toll: Over 134,000 Undiagnosed Cancers During Height of Pandemic Diagnosis rates remained low throughout 2020, with mortality increase projected Feb 22, 2024
Male Fertility Problems in the Family Linked to Cancer Risk Low sperm levels were tied to specific cancers in family members Feb 22, 2024
Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC A non-hormonal therapy control arm is appropriate in trials, says Neeraj Agarwal, MD Feb 22, 2024 video
Radioligand Therapy Continues to Show Promise for Metastatic CRPC Median OS of 15.5 months, PFS of 7.9 months with Ac-225-PSMA in heavily treated patients Feb 16, 2024
More Data Support Olaparib-Abiraterone in BRCA-Mutant Prostate Cancer BRCAAway trial confirms role of combination in first-line setting Feb 15, 2024 video
Novel Antibiotic Combo Bests Meropenem for Complicated UTIs Cefepime-taniborbactam had sustained efficacy for up to a month after treatment Feb 14, 2024
Novel Oral Antibiotic Effective Against Uncomplicated UTIs Gepotidacin could be first new class of oral antibiotics for uncomplicated UTI in over 20 years Feb 12, 2024
Erectile Dysfunction Drugs Tied to Less Alzheimer's Risk Large U.K. study tracked health records of 270,000 men Feb 07, 2024
What We Know About King Charles III's Health History From COVID-19 to polo injuries to "sausage fingers" Feb 06, 2024
Improved Fitness May Reduce Prostate Cancer Risk Observational study finds reduced incidence in men who increased their cardiorespiratory fitness Feb 01, 2024
Peripheral IV Access for Chemo Better Than Central Lines in Testicular Cancer? Retrospective study suggests the technique results in fewer complications, thrombotic events Jan 30, 2024
Some 'Choosing Wisely' Recs Protect Older Folks From Low-Value Care Study looked at how three recommendations changed primary care decisions Jan 29, 2024
Penis-Pump Company Chided by FDA The agency is not enthused by the company's clitoral claims either Jan 29, 2024
One Class of Antidiabetic Linked With Lower Kidney Stone Risk Study compared SGLT2 inhibitors with GLP-1 agonists and DPP-4 inhibitors Jan 29, 2024
First-Line Combo for Cisplatin-Ineligible Bladder Cancer Just Misses Positive Result Cabozantinib-pembrolizumab induced responses in 16 of 35 evaluable patients, but needed one more Jan 29, 2024
More Evidence That ARSIs for Prostate Cancer Differ in Cognitive Effects More fatigue, depression, worse reaction time with enzalutamide as compared with abiraterone Jan 29, 2024
Another Prostate Cancer Screening Candidate Outperforms Standard PSA Testing Multiparametric Stockholm3 avoided far more unnecessary biopsies without sacrificing sensitivity Jan 28, 2024
Cabozantinib Plus Atezolizumab Delays Progression in mCRPC Combination improved PFS versus more hormonal therapy, but control arm questioned Jan 26, 2024
Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone In small first-line trial, PFS more than doubled with combination Jan 26, 2024
Study Supports High-Dose RT, Long-Term ADT as Standard for High-Risk Prostate Cancer OS, PFS, cancer-specific survival all improved, with no increase in toxicity Jan 26, 2024
King Charles Admitted; ADHD Drug Recalled; Minnesota Debates Doc-Assisted Suicide Health news and commentary from around the Web gathered by app staff Jan 26, 2024
Transgender Veterans Sue to Have Gender-Affirming Surgery Covered by VA Lawsuit seeks to compel the VA to codify verbal assurances in its regulations Jan 26, 2024
Multiple Societal Factors Contribute to High HIV Risk in Transgender Women Discrimination, homelessness, low PrEP uptake are key factors, according to CDC survey Jan 25, 2024
Apalutamide Makes Its Case in Biochemically Recurrent Nonmetastatic Prostate Cancer Intensification should be considered for high-risk patients, researchers say Jan 24, 2024
Surgical Volumes Matter for Outcomes at Ambulatory Centers, Too Case-control study looked only at older patients on Medicare, however Jan 24, 2024
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet But opening up can help reduce stigma and inform the public Jan 18, 2024
King Charles III's Surgery; COVID Timeline Doubted; FDA Approvals Hit High Health news and commentary from around the Web gathered by app staff Jan 18, 2024
Fracture Risk Bumped With Testosterone Therapy in Hypogonadal Men Researchers said this was not what they expected to find Jan 17, 2024
Trump and GOP Rivals' Positions on Major Healthcare Issues Here's where the top candidates stand on abortion, the ACA, and gender-affirming care Jan 16, 2024
Surgeon Dies in Plane Crash; Austin Released From Hospital; Animal Pandemic Spreads Health news and commentary from around the Web gathered by app staff Jan 16, 2024
Erectile Dysfunction Drugs Plus Nitrates Still a Losing Combination, Study Shows Cardioprotective effect of PDE5 inhibitors did not pan out with anti-anginals in the picture Jan 16, 2024